Legal Opinion
Bristol-Myers Squibb Co. v. Copley Pharmaceutical, Inc.
District Court, D. Massachusetts
Decided December 29, 2000No. Civ.A. 99-12434-JLTPublishedCited by 10 opinions
1Opinion of the Court
MEMORANDUM
TAURO, District Judge.
BACKGROUND
Plaintiff Bristol-Myers Squibb Co. (“Bristol”), a pharmaceuticals manufacturer, owns and received FDA approval for the “732 Patent,” a patent for the stable flocculated suspension of megestrol acetate in water. In October 1999, Defendant Copley Pharmaceuticals, Inc. (“Copley”), a generic-drug manufacturer, filed with the FDA an Abbreviated New Drug Application (“ANDA”) for approval of a generic version of megestrol acetate oral suspension. The application included a certification that the generic version would not infringe the 732 Patent.
Bristol sued…
2Cases cited6 opinions
- Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc.Supreme Court of the United States · 1977
- Atlantic Richfield Co. v. USA Petroleum Co.Supreme Court of the United States · 1990
- City of Pittsburgh v. West Penn Power Comp., D/B/A Allegheny Power Allegheny Power System, Incorporated Duquesne Light Company Dqe, IncCourt of Appeals for the Third Circuit · 1998
- Novo Nordisk of North America, Inc. v. Genentech, Inc.District Court, S.D. New York · 1995
- Andrx Pharmaceuticals, Inc. v. FriedmanDistrict Court, District of Columbia · 2000
1 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- In Re Ciprofloxacin Hydrochloride Antitrust LitigationDistrict Court, E.D. New York · 2003
- In re Nexium (Esomeprazole) Antitrust LitigationDistrict Court, D. Massachusetts · 2014
- In Re Tamoxifen Citrate Antitrust LitigationDistrict Court, E.D. New York · 2003
- In Re Terazosin Hydrochloride Antitrust LitigationDistrict Court, S.D. Florida · 2004
- Amgen, Inc. v. F. Hoffmann-La Roche Ltd.District Court, D. Massachusetts · 2007
5 more not listed; retrieve them via the Exa API.